ISA247 is currently being investigated in a phase IIb North American trial for the prevention of kidney graft rejection subsequent to transplantation and a phase III European/Canadian psoriasis
Under the terms of the agreement, Diamyd Medical will supply clinical-grade material (i.e., Diamyd and placebo) for the trial. The clinical study will be conducted by the National
In addition, MedMira has recently shipped several follow-on orders to existing European distributors in Germany and The Netherlands. MiraCare HIV is MedMira’s CE-Marked rapid HIV test approved for
In early October, DiaMedica has announced the preliminary results of its Phase II human study with DM-71, which demonstrated the ability of DM-71 to reduce HbA1c when compared
The product’s microsphere formulation as well as sterile filling was accomplished at Oakwood’s Cleveland manufacturing facility. Oakwood Laboratories’ proprietary Chroniject technology has been shown to offer an adaptable
The Phase IIa proof-of-concept trial is designed to assess the effectiveness, safety, tolerability, and pharmacokinetics of four different dose regimens of the drug, TMC435350 (25mg daily, 75mg daily,
The over expression of TCblR in cancer cells provides the rationale for targeting the vitamin B12 receptor in the treatment of various forms of cancer. The isolation of
Revenues for the three months ended September 30, 2007 totaled $1.65 million, up 44.7% compared to revenues of $1.14 million in the third quarter of 2006. The company
Mr Flynt is a certified public accountant with more than 25 years of financial management experience. He has most recently served as vice president, finance, with McKesson in
This next generation computer-aided detection (CAD) system is designed to enhance the overall clinical performance with Senographe and Seno Advantage systems, specifically improving sensitivity to breast cancer imaging,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.